JSON
Lind A, Salami F, Landtblom A, Palm L, Lernmark Å, Adolfsson J, Elding Larsson H
Eur. J. Immunol. 51 (1) 247-249 [2021-01-00; online 2020-07-30]
Increased incidence of narcolepsy type 1 (NT1) was observed following Pandemrix®-vaccination, initiated as a preventive measure against the 2009 Influenza pandemic. Here, single cell analysis was conducted to suggest a lower number of CD8+ CD27+ T cells among these patients. These findings provide understanding into the autoimmune pathogenesis of NT1.
Cellular Immunomonitoring [Service]
PubMed 32671842
DOI 10.1002/eji.202048633
Crossref 10.1002/eji.202048633